Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.
On any given day, the show will cover at least 20 stocks determined by co-hosts Joel Elconin and Dennis Dick along with producer Spencer Israel.
Some Wall Street ratings changes are interesting, and some are really interesting.
Wednesday's downgrade by Goldman Sachs of both Imax Corp IMAX and Cinemark Holdings, Inc. CNK to Sell — with all of Wall Street focused on AMC Entertainment Holdings Inc AMC — tops them all.
These issues are the PreMarket Prep Stocks of the Day, and we're analyzing them from purely a technical standpoint.
The Rationale For Cinemark, Imax Downgrades: Without delving too deep into the fundamentals of the companies, Goldman Sachs analysts stated their views in simple terms.
Although the "reopening trade" has strong momentum, the firm "expects the domestic box office recovery to be more limited than what is currently being priced in."
On a relative basis to other issues in Goldman's coverage area, the sell-side firm said there are potentially other companies that will have a better return based on current risk factors.
The Street's Reaction To Imax: While AMC surges to uncharted territory, Imax Group is in the red, down 1.97% at $21.85 at last check Wednesday.
The price action may not truly reflect how investor sentiment moving forward.
Before Wednesday’s downgrade, the issue made six consecutive lows in a small area ($21.40-$21.55). This can be a signal of patient stock accumulation by large investors who are sticking with their price.
One rule of technical analysis is that old support may become new resistance. After a much lower open Wednesday ($21 vs. $22.74), Imax continued lower but caught a bid just above its May 20 low ($20.57) at $20.64 and sharply reversed course.
This may indicate there are still some large buyers in the issue and the discount afforded to them by downgrade is allowing them to purchase shares at an average price lower than originally targeted.
It should be noted that the issue has rallied over $1 off that low and has continued to make new highs for the session, changing hands at $21.95. Whether this a "dead cat bounce" or resumption of the uptrend is yet to be determined.
The Street's Reaction To Cinemark: In Wednesday’s session, there is a “buy the dip” mentality in shares of Cinemark Holdings. Although the issue did not have a major support area to focus on, similar to Imax, it did fnd support in a familiar area.
Following a lower open ($23.65 vs. $24.41), the continuation move lower did find support just under $23.07 at $22.95.
Cinemark has staged a nice rebound and climbed back into the $24 handle, trading 2.21% higher at $24.95 at last check.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
